News - Townsend Investments
LATEST NEWS:
NovaBiotics News

PRESS RELEASE
European Parliament, Brussels, 22 November 2017
During a high-level event at the European Parliament with biotech CEOs, industry leaders and venture capitalists, MEP Paul R&...

Read More

Dr Deborah O'Neil will present data on Novamycin, a novel peptide antifungal intervention for clinically challenging mycoses in immunocompromised patients.

The 2016 Boul...

Read More

NOVABIOTICS "ONE TO WATCH" FOR 2017.

NovaBiotics has been shortlisted for Biotech & Money's 2016 Assembly & Awards Gala Dinner (to be held ...

Read More

NovaBiotics Ltd (‘NovaBiotics’ or the ‘Company’), the Aberdeen-based clinical-stage biotechnology company, has presented new data showing antibiotic resi...

Read More